No changes in feeding behavior, weight gain, or developmental milestones
Companies in this space include mitochondrial uncouplers with enhanced safety profiles (Rivus, Continuum), GDF15 targeting drugs (Novo, Lilly, Janssen), anti- activin II receptor mAb (Versanis), mir-22 inhibition (Resalis Tx) and gut-brain axis modulators (Kallyope)
Sills, E
By recognising these challenges early, you can take informed steps to preserve your facial aesthetics while still enjoying the health benefits of your weight loss journey
Testimonials reflect individual experiences and are not a guarantee of results
Factors such as starting weight, adherence to medication, and lifestyle choices like diet and physical activity play critical roles in the outcome of the treatment